Trial · NCT00755417
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Average Daily Frequency of Hot Flashes After 4 Weeks of Treatment With Daily Doses of G-ER 1200 mg or G-ER 1800 mg Compared to Placebo | G-ER 1200 mg | -6.8 | 95% Confidence Interval -7.37 to -6.13 | Moderate or severe hot flashes | |
| Change From Baseline in Average Daily Frequency of Hot Flashes After 4 Weeks of Treatment With Daily Doses of G-ER 1200 mg or G-ER 1800 mg Compared to Placebo | G-ER 1800 mg | -7.3 | 95% Confidence Interval -7.89 to -6.71 | Moderate or severe hot flashes | |
| Change From Baseline in Average Daily Frequency of Hot Flashes After 4 Weeks of Treatment With Daily Doses of G-ER 1200 mg or G-ER 1800 mg Compared to Placebo | Sugar Pill | -5.8 | 95% Confidence Interval -6.41 to -5.18 | Moderate or severe hot flashes | |
| Change From Baseline in Average Daily Frequency of Hot Flashes After 12 Weeks of Treatment With Daily Doses of G-ER 1200 mg or G-ER 1800 mg Compared to Placebo | G-ER 1200 mg | -7.4 | 95% Confidence Interval -8.10 to -6.73 | Moderate or severe hot flashes | |
| Change From Baseline in Average Daily Frequency of Hot Flashes After 12 Weeks of Treatment With Daily Doses of G-ER 1200 mg or G-ER 1800 mg Compared to Placebo | G-ER 1800 mg | -7.4 | 95% Confidence Interval -8.04 to -6.74 | Moderate or severe hot flashes | |
| Change From Baseline in Average Daily Frequency of Hot Flashes After 12 Weeks of Treatment With Daily Doses of G-ER 1200 mg or G-ER 1800 mg Compared to Placebo | Sugar Pill | -6.9 | 95% Confidence Interval -7.53 to -6.18 | Moderate or severe hot flashes | |
| Change From Baseline in Average Daily Severity Score of Hot Flashes After 4 Weeks of Treatment With Daily Doses of G-ER 1200 mg or G-ER 1800 mg Compared to Placebo | G-ER 1200 mg | -0.5 | 95% Confidence Interval -0.68 to -0.41 | Score on a numerical scale | |
| Change From Baseline in Average Daily Severity Score of Hot Flashes After 4 Weeks of Treatment With Daily Doses of G-ER 1200 mg or G-ER 1800 mg Compared to Placebo | G-ER 1800 mg | -0.6 | 95% Confidence Interval -0.74 to -0.48 | Score on a numerical scale | |
| Change From Baseline in Average Daily Severity Score of Hot Flashes After 4 Weeks of Treatment With Daily Doses of G-ER 1200 mg or G-ER 1800 mg Compared to Placebo | Sugar Pill | -0.3 | 95% Confidence Interval -0.42 to -0.15 | Score on a numerical scale | |
| Change From Baseline in Average Daily Severity Score of Hot Flashes After 12 Weeks of Treatment With Daily Doses of G-ER 1200 mg or G-ER 1800 mg Compared to Placebo | G-ER 1200 mg | -0.7 | 95% Confidence Interval -0.91 to -0.58 | Score on a numerical scale | |
| Change From Baseline in Average Daily Severity Score of Hot Flashes After 12 Weeks of Treatment With Daily Doses of G-ER 1200 mg or G-ER 1800 mg Compared to Placebo | G-ER 1800 mg | -0.7 | 95% Confidence Interval -0.90 to -0.59 | Score on a numerical scale | |
| Change From Baseline in Average Daily Severity Score of Hot Flashes After 12 Weeks of Treatment With Daily Doses of G-ER 1200 mg or G-ER 1800 mg Compared to Placebo | Sugar Pill | -0.5 | 95% Confidence Interval -0.71 to -0.38 | Score on a numerical scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00755417/results